Axalimogene filolisbac: Phase II data

Top-line data from 8 of the anticipated 9 patients with HPV-associated oropharyngeal cancer expected to be enrolled in stage 1 of an open-label, U.S. Phase II trial showed that 2 IV vaccinations with ...